Clinical trial
Cinacalcet to Treat Hypercalcemia in Renal Transplant Recipients
NCT00415584 · Montefiore Medical Center, Other · Terminated
Key facts
| NCT number | NCT00415584 |
|---|---|
| Title | Cinacalcet to Treat Hypercalcemia in Renal Transplant Recipients |
| Official title | Cinacalcet for Treatment of Persistent Secondary Hyperparathyroidism in Renal Transplant Recipients: Effect on Renal Function, Serum Calcium and Bone Histomorphometry |
| Lead sponsor | Montefiore Medical Center, Other |
| Status | Terminated |
| Phase | Phase 1/Phase 2 |
| Study type | Interventional |
| Conditions | Secondary Hyperparathyroidism, Hypercalcemia |
| Intervention type | Drug |
| Interventions | Cinacalcet HCl |
| Enrollment | 4 |
| Start date | Feb 9, 2007 |
| Primary completion | Nov 1, 2009 |
| Completion | Nov 1, 2009 |
| First posted | Dec 25, 2006 |
| Last update posted | Apr 29, 2025 |
| Countries | United States |
At a glance
- 1–9 Study sites
- Yes Results posted
- None Linked FDA submissions
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About ClinicalTrials.gov studies
ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.
Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date: